Scarica l'app Stockscreener
123.93
0.09%
0.11
Dopo l'orario di chiusura:
124.15
0.22
+0.18%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$123.82
Aprire:
$123.41
Volume 24 ore:
8.45M
Relative Volume:
0.60
Capitalizzazione di mercato:
$307.60B
Reddito:
$65.00B
Utile/perdita netta:
$18.26B
Rapporto P/E:
17.03
EPS:
7.2751
Flusso di cassa netto:
$13.05B
1 W Prestazione:
+1.94%
1M Prestazione:
+14.56%
6M Prestazione:
+41.85%
1 anno Prestazione:
+35.78%
Intervallo 1D:
$122.63
$124.84
Intervallo di 1 settimana:
$120.39
$124.84
Portata 52W:
$73.31
$124.84
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
123.93 | 307.32B | 65.00B | 18.26B | 13.05B | 7.2751 |
|
LLY
Lilly Eli Co
|
1,042.15 | 998.60B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
246.28 | 592.45B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
228.44 | 405.58B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
AZN
Astrazeneca Plc
|
206.61 | 317.72B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
167.11 | 314.27B | 54.72B | 14.02B | 15.32B | 7.1855 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-13 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-10-13 | Ripresa | Citigroup | Neutral |
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
How Is Merck & Co.'s Stock Performance Compared to Other Healthcare Stocks? - Barchart.com
Merck to Participate in the TD Cowen 46th Annual Health Care Conference - PharmiWeb.com
Amazon, Merck, PG&E And More On CNBC's 'Final Trades' - Benzinga
First American Trust FSB Acquires 12,478 Shares of Merck & Co., Inc. $MRK - MarketBeat
Mufg Securities Americas Inc. Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
First Financial Bankshares Inc Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck Animal Health Receives S&P Global Awards for NUMELVI® and INNOVAX® ND-ILT-IBD - global-agriculture.com
Merck (MRK) Announces Positive Phase 3 SMART Trial Results for ENFLONSIA (Clesrovimab) - Finviz
Merck & Co to spin off cancer unit ahead of Keytruda patent cliff - Sharecast.com
Merck (NYSE:MRK) Hits Annual High in Russell 1000 - Kalkine Media
1 Reason I'd Buy Veeva Systems Stock and Never Sell - The Motley Fool
Merck & Co., Inc. (NYSE:MRK) Hits New 52-Week HighTime to Buy? - MarketBeat
Merck & Company, Inc. (MRK) Stock Analysis: Analyst Ratings Signal Strong Buy Potential Amidst Robust Growth - DirectorsTalk Interviews
Barclays Highlights Merck's (MRK) Pipeline Catalysts in Coverage Initiation - Finviz
Barclays Highlights Merck’s (MRK) Pipeline Catalysts in Coverage Initiation - Insider Monkey
Merck to Create a Separate Cancer Unit as Patent Cliff Looms - Bloomberg
Merck's strategic shift signals new growth horizons - MSN
Merck's Strategic Shift Signals New Growth Horizons - Benzinga
Merck reportedly ready to the splits as Keytruda patent cliff looms. Market shrugs - Proactive Investors
Merck to split human health unit into two divisions (MRK:NYSE) - Seeking Alpha
Payden & Rygel Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck Evolves Human Health Operating Structure to Support Portfolio Execution - Business Wire
Merck & Co., Inc. $MRK Shares Sold by Kovitz Investment Group Partners LLC - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
How Merck Is Using 3D Printing To Create Innovative Solutions - CSRwire
Westerkirk Capital Inc. Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck: Why Investors Should Remain Bullish Despite Patent Risks - Seeking Alpha
Lansforsakringar Fondforvaltning AB publ Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Hillsdale Investment Management Inc. Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Lifted by EDENTREE ASSET MANAGEMENT Ltd - MarketBeat
Smead Capital Management Inc. Has $254.70 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Tredje AP fonden Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Barclays Upgrades Merck & Co., Inc. (NYSE:MRK) to Strong-Buy - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by ANTIPODES PARTNERS Ltd - MarketBeat
AMG National Trust Bank Acquires 45,996 Shares of Merck & Co., Inc. $MRK - MarketBeat
Deutsche Bank Upgrades Merck (MRK) to Buy, Sees "Clear Path" Beyond Keytruda Patent Cliff - Finviz
Deutsche Bank Upgrades Merck (MRK) to Buy, Sees “Clear Path” Beyond Keytruda Patent Cliff - Insider Monkey
Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026? - Finviz
Merck & Co. (MRK) advances on robust Keytruda sales and positive clinical trial results - MSN
Merck & Co., Inc. (NYSE:MRK) Now Covered by Analysts at Barclays - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by ICICI Prudential Asset Management Co Ltd - MarketBeat
Here Are Friday’s Top Wall Street Analyst Research Calls: Amgen, ETSY, Eldorado Gold, GE Aerospace, Merck, Southern Company, Walmart, Yeti, and More - 24/7 Wall St.
NewEdge Wealth LLC Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
29,451 Shares in Merck & Co., Inc. $MRK Bought by CenterBook Partners LP - MarketBeat
MRK Stock Price, Forecast & Analysis | MERCK & CO. INC. (NYSE:MRK) - ChartMill
Where is Merck & Co., Inc. (MRK) Headed According to the Street? - Finviz
Merck posts new Enflonsia RSV data in infants (MRK:NYSE) - Seeking Alpha
King Luther Capital Management Corp Sells 263,609 Shares of Merck & Co., Inc. $MRK - MarketBeat
Burling Wealth Partners LLC Sells 9,333 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Prospector Partners LLC - MarketBeat
First National Bank of Omaha Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.46%
0.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):